Clinical Trial: ALLIANCE A082002

ALLIANCE A082002

Status: New, Open

A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer